Davis Polk advised the joint book-running managers in the offering. Solid Biosciences Inc. executed the $143.75 million public offering of common stock. The common stock is listed...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented the underwriters in the offering while Wilson Sonsini Goodrich & Rosati advised Design Therapeutics, Inc. Design Therapeutics, Inc. executed its initial public...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP and Maples and Calder represented Connect Biopharma in the transaction. Global Law Office and Davis Polk advised joint book-running managers. Connect Biopharma...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised the initial purchasers on the deal. MannKind Corporation (the “Company”) completed its previously announced private offering (the “Offering”) of $200.0 million aggregate...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers in the offering. Adamas Pharmaceuticals, Inc. executed its $59 million follow-on offering of 14,375,000 shares of common stock, which included...
You must be a Standard 1 Year member to access this content.
Gornitzky represented the underwriters on the deal. Itamar Medical Ltd. completed a $79.8 million public offering of American Depositary Shares (ADSs) on the Nasdaq Capital Market....
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented the initial purchasers in the offering. Peloton Interactive, Inc. (Peloton) (Nasdaq: PTON) has closed its offering of 0% convertible senior notes due...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented the underwriters in the offering of Athenex, assisted by Harter Secrest & Emery LLP. Athenex, Inc. announced the pricing of a...
You must be a Standard 1 Year member to access this content.
